JHS Svendgaard Laboratories Limited (JHS.NS)
INR 22.38
(0.41%)
INR 22.38
(0.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 271.7 Million INR | -51.38% |
| 2022 | 558.87 Million INR | 107.41% |
| 2021 | 269.45 Million INR | -10.17% |
| 2020 | 299.96 Million INR | -46.74% |
| 2019 | 563.19 Million INR | 38.88% |
| 2018 | 405.53 Million INR | 20.39% |
| 2017 | 336.83 Million INR | 60.93% |
| 2016 | 209.3 Million INR | 3.31% |
| 2015 | 202.6 Million INR | -59.6% |
| 2014 | 501.44 Million INR | -60.59% |
| 2013 | 1.27 Billion INR | -10.29% |
| 2012 | 1.41 Billion INR | 20.13% |
| 2011 | 1.18 Billion INR | 63.59% |
| 2010 | 721.7 Million INR | 5.6% |
| 2009 | 683.44 Million INR | 24.6% |
| 2008 | 548.5 Million INR | 22.48% |
| 2007 | 447.82 Million INR | 171.1% |
| 2006 | 165.18 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -1.69 Billion INR | -725.25% |
| 2023 Q4 | 271.7 Million INR | 0.0% |
| 2023 Q2 | 258.96 Million INR | 0.0% |
| 2023 FY | 271.7 Million INR | -51.38% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 558.87 Million INR | 107.41% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 334.9 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 558.87 Million INR | 0.0% |
| 2021 Q2 | 338.29 Million INR | 0.0% |
| 2021 Q4 | 269.45 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 269.45 Million INR | -10.17% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 675.07 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 299.96 Million INR | 0.0% |
| 2020 FY | 299.96 Million INR | -46.74% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 453.65 Million INR | 0.0% |
| 2019 FY | 563.19 Million INR | 38.88% |
| 2019 Q4 | 563.19 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 370.72 Million INR | 0.0% |
| 2018 FY | 405.53 Million INR | 20.39% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 405.53 Million INR | 0.0% |
| 2017 FY | 336.83 Million INR | 60.93% |
| 2017 Q2 | 248.01 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 336.83 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 209.3 Million INR | 0.0% |
| 2016 FY | 209.3 Million INR | 3.31% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 210.21 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q2 | 412.21 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 202.6 Million INR | 0.0% |
| 2015 FY | 202.6 Million INR | -59.6% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 1.27 Billion INR | 0.0% |
| 2014 FY | 501.44 Million INR | -60.59% |
| 2014 Q4 | 501.44 Million INR | 0.0% |
| 2013 Q2 | 1.47 Billion INR | 0.0% |
| 2013 Q4 | 1.27 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 1.27 Billion INR | -10.29% |
| 2012 Q2 | 3.16 Billion INR | 0.0% |
| 2012 FY | 1.41 Billion INR | 20.13% |
| 2012 Q4 | 1.41 Billion INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2011 FY | 1.18 Billion INR | 63.59% |
| 2010 FY | 721.7 Million INR | 5.6% |
| 2009 FY | 683.44 Million INR | 24.6% |
| 2008 FY | 548.5 Million INR | 22.48% |
| 2007 FY | 447.82 Million INR | 171.1% |
| 2006 FY | 165.18 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | 75.295% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | 82.242% |
| BCL Industries Limited | 6.27 Billion INR | 95.668% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | 97.945% |
| Cupid Limited | 186.52 Million INR | -45.667% |
| Dabur India Limited | 48.19 Billion INR | 99.436% |
| Emami Limited | 8.21 Billion INR | 96.695% |
| Gillette India Limited | 8.59 Billion INR | 96.839% |
| Godrej Consumer Products Limited | 58.97 Billion INR | 99.539% |
| Hindustan Unilever Limited | 270.76 Billion INR | 99.9% |
| Honasa Consumer Limited | 5.36 Billion INR | 94.938% |
| Jyothy Labs Limited | 5.9 Billion INR | 95.4% |
| Kaya Limited | 5.22 Billion INR | 94.797% |
| Marico Limited | 32.52 Billion INR | 99.164% |
| N.K Industries Limited | 22.4 Billion INR | 98.787% |
| Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 97.493% |
| S H Kelkar and Company Limited | 11.88 Billion INR | 97.713% |